BioSpace News Archive

Chemomab Therapeutics Ltd. announced that Chemomab co-founder, Chief Executive Officer and Chief Scientific Officer Adi Mor, PhD, will discuss the CM-101 clinical program in primary sclerosing cholangitis at the 2023 Roth MKM Healthcare Opportunities Conference on October 12, 2023.

BioLineRx Ltd. announced encouraging data from the single-arm pilot phase of the investigator-initiated CheMo4METPANC Phase 2 combination clinical trial evaluating the company’s CXCR4 inhibitor motixafortide, the PD-1 inhibitor cemiplimab, and standard of care chemotherapies gemcitabine and nab-paclitaxel, versus gemcitabine and nab-paclitaxel alone, in first-line pancreatic cancer.

Peptone, a leader in translational biophysics and the design of novel therapeutics against intrinsically disordered proteins, announced the appointment of key leaders to its Executive Management Team and Board of Directors.

Genflow is pleased to announce its half year results for the six-month period ended 30 June 2023.

Bionomics Limited announced positive topline results from its Phase 2b ATTUNE trial of BNC210 for the treatment of PTSD, as described more fully below.